Dietary bioactive compounds are currently being investigated to complement therapeutic strategies to prevent or combat many diseases including non-alcoholic fatty liver disease (NAFLD) and leptin resistance [1,2,3]. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.